Literature DB >> 8609232

Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome.

M Kumagai1, A Manabe, C H Pui, F G Behm, S C Raimondi, M L Hancock, H Mahmoud, W M Crist, D Campana.   

Abstract

We developed a stroma cell culture system that suppresses apoptosis of malignant cells from cases of B-lineage acute lymphoblastic leukemia. By multiparameter flow cytometric measurements of cell recovery after culture on stromal layers, we assessed the growth potential of 70 cases of newly diagnosed B-lineage acute lymphoblastic leukemia and related the findings of treatment outcome in a single program of chemotherapy. The numbers of leukemic cells recovered after 7 d of culture ranged from < 1 to 292% (median, 91%). The basis of poor cell recoveries from stromal layers appeared to be a propensity of the lymphoblasts to undergo apoptosis. The probability of event-free survival at 4 yr of follow-up was 50 +/- 9% (SE) among patients with higher cell recoveries ( > 91%), and 94 +/- 6% among those with reduced cell recoveries (+/- 91%; P = 0.0003). The prognostic value of leukemic cell recovery after culture exceeded estimates for all other recognized high-risk features and remained the most significant after adjustment with all competing covariates. Thus, the survival ability of leukemic cells on bone marrow-derived stromal layers reflects aggressiveness of the disease and is a powerful, independent predictor of treatment outcome in children with B-lineage acute lymphoblastic leukemia.

Entities:  

Mesh:

Year:  1996        PMID: 8609232      PMCID: PMC507113          DOI: 10.1172/JCI118474

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  PITSLRE protein kinase activity is associated with apoptosis.

Authors:  J M Lahti; J Xiang; L S Heath; D Campana; V J Kidd
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

Review 2.  Childhood leukemias.

Authors:  C H Pui
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

Review 3.  Biology and treatment of acute lymphoblastic leukemia.

Authors:  C H Pui; W M Crist
Journal:  J Pediatr       Date:  1994-04       Impact factor: 4.406

4.  Genetic instability in the development of drug resistance.

Authors:  J H Goldie; A J Coldman
Journal:  Semin Oncol       Date:  1985-09       Impact factor: 4.929

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis.

Authors:  L M Secker-Walker; S D Lawler; R M Hardisty
Journal:  Br Med J       Date:  1978-12-02

7.  Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.

Authors:  F M Uckun; H Sather; G Reaman; J Shuster; V Land; M Trigg; R Gunther; L Chelstrom; A Bleyer; P Gaynon
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

8.  Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia.

Authors:  A Manabe; E Coustan-Smith; M Kumagai; F G Behm; S C Raimondi; C H Pui; D Campana
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

9.  Ligation of CD38 suppresses human B lymphopoiesis.

Authors:  M Kumagai; E Coustan-Smith; D J Murray; O Silvennoinen; K G Murti; W E Evans; F Malavasi; D Campana
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  24 in total

1.  Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.

Authors:  Christian Flotho; Elaine Coustan-Smith; Deqing Pei; Shotaro Iwamoto; Guangchun Song; Cheng Cheng; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Blood       Date:  2006-04-20       Impact factor: 22.113

2.  Osteoblasts protect AML cells from SDF-1-induced apoptosis.

Authors:  Kimberly N Kremer; Amel Dudakovic; Meghan E McGee-Lawrence; Rachael L Philips; Allan D Hess; B Douglas Smith; Andre J van Wijnen; Judith E Karp; Scott H Kaufmann; Jennifer J Westendorf; Karen E Hedin
Journal:  J Cell Biochem       Date:  2014-06       Impact factor: 4.429

3.  Apoptosis in haematological malignancies.

Authors:  J A DiGiuseppe; M B Kastan
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

4.  Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.

Authors:  Yao-Te Hsieh; Eun Ji Gang; Huimin Geng; Eugene Park; Sandra Huantes; Doreen Chudziak; Katrin Dauber; Paul Schaefer; Carlton Scharman; Hiroyuki Shimada; Seyedmehdi Shojaee; Lars Klemm; Reshmi Parameswaran; Mignon Loh; Eun-Suk Kang; Hong Hoe Koo; Wolf-Karsten Hofmann; Jacob Andrade; Gay M Crooks; Cheryl L Willman; Markus Müschen; Thalia Papayannopoulou; Nora Heisterkamp; Halvard Bönig; Yong-Mi Kim
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

5.  Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.

Authors:  Francis Mussai; Dario Campana; Deepa Bhojwani; Maryalice Stetler-Stevenson; Seth M Steinberg; Alan S Wayne; Ira Pastan
Journal:  Br J Haematol       Date:  2010-06-07       Impact factor: 6.998

6.  Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.

Authors:  Ashok Srinivasan; John C Panetta; Shane J Cross; Asha Pillai; Brandon M Triplett; David R Shook; Mari H Dallas; Christine Hartford; Anusha Sunkara; Guolian Kang; Jeffrey Jacobsen; John Choi; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2014-04-23       Impact factor: 5.742

Review 7.  Infant acute lymphoblastic leukemia: Lessons learned and future directions.

Authors:  Rob Pieters
Journal:  Curr Hematol Malig Rep       Date:  2009-07       Impact factor: 3.952

8.  Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

Authors:  Shotaro Iwamoto; Keichiro Mihara; James R Downing; Ching-Hon Pui; Dario Campana
Journal:  J Clin Invest       Date:  2007-03-22       Impact factor: 14.808

9.  Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.

Authors:  Olga Frolova; Ismael Samudio; Juliana Maria Benito; Rodrigo Jacamo; Steven M Kornblau; Ana Markovic; Wendy Schober; Hongbo Lu; Yi Hua Qiu; Daniela Buglio; Teresa McQueen; Sherry Pierce; Elizabeth Shpall; Sergej Konoplev; Deborah Thomas; Hagop Kantarjian; Richard Lock; Michael Andreeff; Marina Konopleva
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

10.  Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts.

Authors:  Santi Suryani; Hernan Carol; Triona Ni Chonghaile; Viktoras Frismantas; Chintanu Sarmah; Laura High; Beat Bornhauser; Mark J Cowley; Barbara Szymanska; Kathryn Evans; Ingrid Boehm; Elise Tonna; Luke Jones; Donya Moradi Manesh; Raushan T Kurmasheva; Catherine Billups; Warren Kaplan; Anthony Letai; Jean-Pierre Bourquin; Peter J Houghton; Malcolm A Smith; Richard B Lock
Journal:  Clin Cancer Res       Date:  2014-07-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.